Medication compounded by a state-licensed pharmacy, ideally a 503(a) compounding facility or a 503B outsourcing facility, with documented sterility and quality controls
So, people may feel less hungry and their blood sugar can also be better handled
Treatment should be discontinued if inadequate response occurs: less than 5% weight loss after 6 months for Wegovy or 12 weeks for Saxenda at maintenance doses
Waiting ensures: More predictable, longer-lasting results Reduced risk of needing revision surgery due to ongoing weight changes Most patients are advised to maintain a stable weight for several months before proceeding with body contouring, facial surgery, or breast procedures
Fats (like avocado or olive oil) delay stomach emptying, mimicking GLP-1s effect
Retatrutide: Still undergoing clinical trials, Retatrutide shows promising potential for both glucose control and weight reduction